In a Phase III clinical trial, Neuroderm’s liquid, under-the-skin levodopa/carbidopa controls symptoms better than levodopa pills in people with progressing Parkinson’s.
— Read on www.michaeljfox.org/news/new-parkinsons-drug-formulation-shows-positive-phase-iii-trial-results